Goldman Sachs’s X4 Pharmaceuticals XFOR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $35.8K | Sell |
18,864
-255,001
| -93% | -$485K | ﹤0.01% | 5008 |
|
2025
Q1 | $64.7K | Sell |
273,865
-203,773
| -43% | -$48.2K | ﹤0.01% | 4884 |
|
2024
Q4 | $350K | Buy |
477,638
+185,053
| +63% | +$136K | ﹤0.01% | 4465 |
|
2024
Q3 | $196K | Buy |
292,585
+121,395
| +71% | +$81.3K | ﹤0.01% | 4500 |
|
2024
Q2 | $99.3K | Sell |
171,190
-887,740
| -84% | -$515K | ﹤0.01% | 4501 |
|
2024
Q1 | $1.47M | Buy |
1,058,930
+986,142
| +1,355% | +$1.37M | ﹤0.01% | 3370 |
|
2023
Q4 | $61K | Buy |
72,788
+23,195
| +47% | +$19.4K | ﹤0.01% | 4524 |
|
2023
Q3 | $54.1K | Sell |
49,593
-284,848
| -85% | -$310K | ﹤0.01% | 4477 |
|
2023
Q2 | $649K | Buy |
334,441
+250,959
| +301% | +$487K | ﹤0.01% | 3843 |
|
2023
Q1 | $72.6K | Buy |
83,482
+28,502
| +52% | +$24.8K | ﹤0.01% | 4712 |
|
2022
Q4 | $54.6K | Sell |
54,980
-400
| -0.7% | -$397 | ﹤0.01% | 4777 |
|
2022
Q3 | $95K | Buy |
+55,380
| New | +$95K | ﹤0.01% | 4932 |
|
2022
Q1 | – | Sell |
-20,949
| Closed | -$48K | – | 5906 |
|
2021
Q4 | $48K | Buy |
20,949
+10,474
| +100% | +$24K | ﹤0.01% | 5363 |
|
2021
Q3 | $55K | Sell |
10,475
-43,532
| -81% | -$229K | ﹤0.01% | 5171 |
|
2021
Q2 | $351K | Sell |
54,007
-29,030
| -35% | -$189K | ﹤0.01% | 4622 |
|
2021
Q1 | $715K | Buy |
83,037
+27,031
| +48% | +$233K | ﹤0.01% | 4135 |
|
2020
Q4 | $360K | Buy |
56,006
+4,588
| +9% | +$29.5K | ﹤0.01% | 3998 |
|
2020
Q3 | $348K | Buy |
51,418
+19,835
| +63% | +$134K | ﹤0.01% | 3828 |
|
2020
Q2 | $294K | Buy |
31,583
+17,433
| +123% | +$162K | ﹤0.01% | 3836 |
|
2020
Q1 | $142K | Sell |
14,150
-4,975
| -26% | -$49.9K | ﹤0.01% | 4070 |
|
2019
Q4 | $205K | Buy |
19,125
+4,280
| +29% | +$45.9K | ﹤0.01% | 3979 |
|
2019
Q3 | $189K | Sell |
14,845
-17,180
| -54% | -$219K | ﹤0.01% | 3930 |
|
2019
Q2 | $480K | Buy |
+32,025
| New | +$480K | ﹤0.01% | 3546 |
|
2019
Q1 | – | Sell |
-23,336
| Closed | -$54K | – | 4267 |
|
2018
Q4 | $54K | Buy |
+23,336
| New | +$54K | ﹤0.01% | 3965 |
|